About
Mission/Vision
Our Team
Board of Directors
Elite Members
Why Utah?
Life Sciences Report
Partnerships
Jobs
Membership
Why Join BioUtah?
Membership Prospectus
Member Login
Apply for Membership
Life Sciences Jobs
Member Discounts
Non-dilutive Funding
Membership Directory
Advocacy
News/Info
Biosphere Magazine
Life Sciences News
Reports/Publications
Podcasts
Events
BioUtah Events
Industry Events
Newsletter
Biosphere
Magazine
About
Mission/Vision
Our Team
Board of Directors
Elite Members
Why Utah?
Life Sciences Report
Partnerships
Jobs
Membership
Why Join BioUtah?
Membership Prospectus
Member Login
Apply for Membership
Life Sciences Jobs
Member Discounts
Non-dilutive Funding
Membership Directory
Advocacy
News/Info
Biosphere Magazine
Life Sciences News
Reports/Publications
Podcasts
Events
BioUtah Events
Industry Events
Newsletter
Biosphere
Magazine
Join Now
Pathos AI Secures $365 Million in Series D Financing to Advance Oncology Drug Development Through AI
By
Press Release
|
Published
May 22, 2025
Pathos AI Secures $365 Million in Series D Financing to Advance Oncology Drug Development Through AI
Posted in
BioUtah News
|
Tagged
pathos ai
|
Comments Off
on Pathos AI Secures $365 Million in Series D Financing to Advance Oncology Drug Development Through AI